We use cookies to customize content for your viewing and for analytics. If you continue to browse this website, we will assume that you are happy to receive all our cookies. For further information please read our cookie policy.
Giovanni Caforio, M.D.
Director since 2020, Compensation and Human Capital Committee, Governance and Nominating Committee
Former Chairman and CEO, Bristol Myers Squibb
Dr. Caforio is the former Chairman and CEO of Bristol Myers Squibb, Chairman from May 2017 to November 1, 2023 and CEO from May 2015 to November 1, 2023. Previously, he spent 12 years with Abbott Laboratories in a number of leadership positions. Dr. Caforio also served as the Chairman of the Pharmaceutical Research and Manufacturers of America (PhRMA), a trade association representing pharmaceutical companies in the United States.
Dr. Caforio adds extensive experience to our Board as both a physician and a business leader. As the former CEO of a leading global biopharmaceutical company, he oversaw the acquisition of Celgene, led the company’s focus on researching and developing transformational medicines and advanced scientific innovation that has helped improve the lives of patients. This experience enables him to provide valuable business, leadership and management insights to our Board.
